feed,title,long_url,short_url
MedRxiv:HI,Longitudinal assessment of ROPRO as an early indicator of overall survival in oncology clinical trials: a retrospective analysis,https://medrxiv.org/cgi/content/short/2022.10.11.22280399v1?rss=1,https://bit.ly/3TfxrgX
